News OPKO Health, Inc.

Equities

OPK

US68375N1037

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
1.26 ^USD	+3.70%		+0.80%	-16.56%

May. 07	Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M	MT
May. 07	Opko Health, Inc. Provides Earnings Guidance for the Second Quarter of 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

OPKO Health : Immediate Report	Jun. 29	PU
OPKO Health to Participate in the Jefferies Global Healthcare Conference	Jun. 03	AQ
OPKO Health to Participate in the Jefferies Global Healthcare Conference	May. 31	AQ
OPKO Health : Immediate Report	May. 24	PU
OPKO Health : Immediate Report	May. 18	PU
Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M	May. 07	MT
OPKO Health: Q1 Earnings Snapshot	May. 07	AQ
Opko Health, Inc. Provides Earnings Guidance for the Second Quarter of 2024	May. 07	CI
Transcript : OPKO Health, Inc., Q1 2024 Earnings Call, May 07, 2024	May. 07
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results	May. 07	AQ
OPKO Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024	May. 06	AQ
OPKO Health : Immediate Report	May. 04	PU
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024	May. 03	AQ
InvestorBrandMedia: Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc. (NYSEAMERICAN: ATNM) Amidst Groundbreaking Cancer Therapy Innovations	Apr. 01	AQ
Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets	Mar. 28	MT
Transcript : OPKO Health, Inc. - Shareholder/Analyst Call	Mar. 28
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome	Mar. 20	AQ
Entera Bio Announces Robust Pharmacokinetic Data for First-In-Class Oral Glp-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome	Mar. 20	CI
OPKO Health : Immediate Report	Mar. 15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News OPKO Health, Inc.

Equities

OPK

US68375N1037

Summary

Filters